6877 Stock Overview
An investment holding company, sells healthcare products and other services in Australia, Hong Kong, and New Zealand. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 3/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
CLSA Premium Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | HK$0.098 |
52 Week High | HK$0.15 |
52 Week Low | HK$0.071 |
Beta | 1.41 |
1 Month Change | 8.89% |
3 Month Change | 22.50% |
1 Year Change | n/a |
3 Year Change | -14.04% |
5 Year Change | -70.30% |
Change since IPO | -78.92% |
Recent News & Updates
Shareholder Returns
6877 | HK Capital Markets | HK Market | |
---|---|---|---|
7D | -2.0% | -3.4% | -0.5% |
1Y | n/a | 30.8% | 19.9% |
Return vs Industry: Insufficient data to determine how 6877 performed against the Hong Kong Capital Markets industry.
Return vs Market: Insufficient data to determine how 6877 performed against the Hong Kong Market.
Price Volatility
6877 volatility | |
---|---|
6877 Average Weekly Movement | 15.5% |
Capital Markets Industry Average Movement | 14.3% |
Market Average Movement | 8.8% |
10% most volatile stocks in HK Market | 18.6% |
10% least volatile stocks in HK Market | 4.1% |
Stable Share Price: 6877's share price has been volatile over the past 3 months compared to the Hong Kong market.
Volatility Over Time: Insufficient data to determine 6877's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2010 | 13 | n/a | www.clsapremium.com |
CLSA Premium Limited, an investment holding company, sells healthcare products and other services in Australia, Hong Kong, and New Zealand. The company operates through Healthcare Products and Margin Dealing segments. It also offers leveraged foreign exchange trading, commodity and index trading, leveraged bullion, and other trading services.
CLSA Premium Limited Fundamentals Summary
6877 fundamental statistics | |
---|---|
Market cap | HK$199.26m |
Earnings (TTM) | HK$12.16m |
Revenue (TTM) | HK$112.55m |
16.4x
P/E Ratio1.8x
P/S RatioIs 6877 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
6877 income statement (TTM) | |
---|---|
Revenue | HK$112.55m |
Cost of Revenue | HK$67.51m |
Gross Profit | HK$45.03m |
Other Expenses | HK$32.88m |
Earnings | HK$12.16m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.006 |
Gross Margin | 40.01% |
Net Profit Margin | 10.80% |
Debt/Equity Ratio | 0% |
How did 6877 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/23 01:29 |
End of Day Share Price | 2024/12/23 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
CLSA Premium Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|